Michael Stowasser

Jul 17, 2024 | nature.com | Sonali Shah |Michael Stowasser |Morag J Young |Peter Fuller

AbstractLow-renin hypertension affects 1 in 4 people with hypertension, but the optimal management of this condition is not known. We hypothesize that a large proportion of people with low-renin hypertension is mediated by excess mineralocorticoid receptor (MR) activation and that targeted treatment with an MR antagonist (MRA) will be beneficial.

Apr 2, 2024 | ahajournals.org | James Sharman |Petr Otahal |Michael Stowasser |Tony Stanton

BACKGROUND:Cuff blood pressure (BP) is recommended for guiding hypertension management. However, central BP has been proposed as a superior clinical measurement. This study aimed to determine whether controlling hypertension as measured by central BP was beneficial in reducing left ventricular mass index beyond control of standard cuff hypertension.